Literature DB >> 12236867

Veterinary ophthalmology in laboratory animal studies.

Robert J Munger1.   

Abstract

In this overview the current status of the role of veterinary ophthalmology in laboratory animal studies is discussed. Attention is devoted to current regulatory requirements and study construction, examination techniques commonly used in studies, and a consideration of species characteristics that may be important to investigators. Methods for recording data are discussed with examples of recording systems.

Mesh：

Year:  2002        PMID： 12236867     DOI： 10.1046/j.1463-5224.2002.00243.x

Source DB:  PubMed          Journal:  Vet Ophthalmol        ISSN： 1463-5216            Impact factor:   1.644


  12 in total

1.  Species Differences in the Geometry of the Anterior Segment Differentially Affect Anterior Chamber Cell Scoring Systems in Laboratory Animals.

Authors:  Sara M Thomasy; J Seth Eaton; Matthew J Timberlake; Paul E Miller; Steven Matsumoto; Christopher J Murphy
Journal:  J Ocul Pharmacol Ther       Date:  2015-11-05       Impact factor: 2.671

2.  Safety and efficacy of topically administered netarsudil (Rhopressa™) in normal and glaucomatous dogs with ADAMTS10-open-angle glaucoma (ADAMTS10-OAG).

Authors:  Kelly A Leary; Kuan-Ting Lin; Juan P Steibel; Christine D Harman; András M Komáromy
Journal:  Vet Ophthalmol       Date:  2019-12-24       Impact factor: 1.644

3.  Biocompatibility and biodegradation studies of subconjunctival implants in rabbit eyes.

Authors:  Yan Peng; Marcus Ang; Selin Foo; Wing Sum Lee; Zhen Ma; Subbu S Venkatraman; Tina T Wong
Journal:  PLoS One       Date:  2011-07-22       Impact factor: 3.240

4.  Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye.

Authors:  Jayaganesh V Natarajan; Marcus Ang; Anastasia Darwitan; Sujay Chattopadhyay; Tina T Wong; Subbu S Venkatraman
Journal:  Int J Nanomedicine       Date:  2012-01-05

5.  Evaluation of a Sustained-Release Prednisolone Acetate Biodegradable Subconjunctival Implant in a Non-Human Primate Model.

Authors:  Yu-Chi Liu; Anthony Herr Cheun Ng; Xu Wen Ng; Peng Yan; Subbu S Venkatraman; Jodhbir S Mehta; Tina T Wong
Journal:  Transl Vis Sci Technol       Date:  2017-10-05       Impact factor: 3.283

6.  Effect of a Soluble Epoxide Hydrolase Inhibitor, UC1728, on LPS-Induced Uveitis in the Rabbit.

Authors:  Gillian J McLellan; Zeynep Aktas; Elizabeth Hennes-Beean; Aaron W Kolb; Inna V Larsen; Emily J Schmitz; Hilary R Clausius; Jun Yang; Sung Hee Hwang; Christophe Morisseau; Bora Inceoglu; Bruce D Hammock; Curtis R Brandt
Journal:  J Ocul Biol       Date:  2016-01-12

7.  Once-Daily Cyclosporine-A-MiDROPS for Treatment of Dry Eye Disease.

Authors:  Terry G Coursey; Ronald A Wassel; Alexander B Quiambao; Rafal A Farjo
Journal:  Transl Vis Sci Technol       Date:  2018-10-10       Impact factor: 3.283

8.  Serum vascular endothelial growth factor changes and safety after topical anti-human VEGF antibody bevacizumab in healthy dogs.

Authors:  Lisa-Marie Muellerleile; Alexander Tichy; Barbara Nell
Journal:  Vet Ophthalmol       Date:  2019-02-04       Impact factor: 1.644

9.  A biodegradable, sustained-released, prednisolone acetate microfilm drug delivery system effectively prolongs corneal allograft survival in the rat keratoplasty model.

Authors:  Yu-Chi Liu; Yan Peng; Nyein Chan Lwin; Subbu S Venkatraman; Tina T Wong; Jodhbir S Mehta
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

10.  Serp-1 Promotes Corneal Wound Healing by Facilitating Re-epithelialization and Inhibiting Fibrosis and Angiogenesis.

Authors:  Brent Ju; Owen Guo; Dathe Z Benissan-Messan; McKinley H Shawver; Peng Chen; Bingchuan Geng; Siqi Wei; Jordan R Yaron; Alexandra R Lucas; Hua Zhu
Journal:  Front Cardiovasc Med       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.